Pamela B. Cassidy - Search Results

Year	Number of Results
2002	1
2003	1
2006	1
2010	1
2012	1
2013	2
2014	2
2015	3
2016	2
2017	4
2018	3
2019	3
2020	3
2021	2
2022	4
2024	1

1

Guselkumab for Pityriasis Rubra Pilaris and Dysregulation of IL-23/IL-17 and NFkB Signaling: A Nonrandomized Trial.

Velasco RC, Shao C, Cutler B, Strunck J, Kent G, Cassidy PB, Choate K, Greiling TM. Velasco RC, et al. Among authors: cassidy pb. JAMA Dermatol. 2024 Apr 10:e240257. doi: 10.1001/jamadermatol.2024.0257. Online ahead of print. JAMA Dermatol. 2024. PMID: 38598229

2

MITF Is Regulated by Redox Signals Controlled by the Selenoprotein Thioredoxin Reductase 1.

Kline CD, Anderson M, Bassett JW, Kent G, Berryman R, Honeggar M, Ito S, Wakamatsu K, Indra AK, Moos PJ, Leachman SA, Cassidy PB. Kline CD, et al. Among authors: cassidy pb. Cancers (Basel). 2022 Oct 13;14(20):5011. doi: 10.3390/cancers14205011. Cancers (Basel). 2022. PMID: 36291795 Free PMC article.

3

Slip versus Slop: A Head-to-Head Comparison of UV-Protective Clothing to Sunscreen.

Berry EG, Bezecny J, Acton M, Sulmonetti TP, Anderson DM, Beckham HW, Durr RA, Chiba T, Beem J, Brash DE, Kulkarni R, Cassidy PB, Leachman SA. Berry EG, et al. Among authors: cassidy pb. Cancers (Basel). 2022 Jan 21;14(3):542. doi: 10.3390/cancers14030542. Cancers (Basel). 2022. PMID: 35158810 Free PMC article.

4

Thioredoxin Reductase 1 Modulates Pigmentation and Photobiology of Murine Melanocytes in vivo.

Carpenter EL, Wyant MB, Indra A, Ito S, Wakamatsu K, Merrill GF, Moos PJ, Cassidy PB, Leachman SA, Ganguli-Indra G, Indra AK. Carpenter EL, et al. Among authors: cassidy pb. J Invest Dermatol. 2022 Jul;142(7):1903-1911.e5. doi: 10.1016/j.jid.2021.11.030. Epub 2022 Jan 11. J Invest Dermatol. 2022. PMID: 35031135 Free PMC article.

5

Molecular and Cellular Characterization of Pyoderma Gangrenosum: Implications for the Use of Gene Expression.

Ortega-Loayza AG, Friedman MA, Reese AM, Liu Y, Greiling TM, Cassidy PB, Marzano AV, Gao L, Fei SS, Rosenbaum JT. Ortega-Loayza AG, et al. Among authors: cassidy pb. J Invest Dermatol. 2022 Apr;142(4):1217-1220.e14. doi: 10.1016/j.jid.2021.08.431. Epub 2021 Sep 15. J Invest Dermatol. 2022. PMID: 34536481 Free article. No abstract available.

6

The State of Melanoma: Emergent Challenges and Opportunities.

Atkins MB, Curiel-Lewandrowski C, Fisher DE, Swetter SM, Tsao H, Aguirre-Ghiso JA, Soengas MS, Weeraratna AT, Flaherty KT, Herlyn M, Sosman JA, Tawbi HA, Pavlick AC, Cassidy PB, Chandra S, Chapman PB, Daud A, Eroglu Z, Ferris LK, Fox BA, Gershenwald JE, Gibney GT, Grossman D, Hanks BA, Hanniford D, Hernando E, Jeter JM, Johnson DB, Khleif SN, Kirkwood JM, Leachman SA, Mays D, Nelson KC, Sondak VK, Sullivan RJ, Merlino G; Melanoma Research Foundation. Atkins MB, et al. Among authors: cassidy pb. Clin Cancer Res. 2021 May 15;27(10):2678-2697. doi: 10.1158/1078-0432.CCR-20-4092. Epub 2021 Jan 7. Clin Cancer Res. 2021. PMID: 33414132 Free PMC article.

7

A Diselenide Turn-On Fluorescent Probe for the Detection of Thioredoxin Reductase.

Mafireyi TJ, Laws M, Bassett JW, Cassidy PB, Escobedo JO, Strongin RM. Mafireyi TJ, et al. Among authors: cassidy pb. Angew Chem Int Ed Engl. 2020 Aug 24;59(35):15147-15151. doi: 10.1002/anie.202004094. Epub 2020 Jun 17. Angew Chem Int Ed Engl. 2020. PMID: 32449244 Free PMC article.

8

Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial.

Haynes D, Strunck JL, Topham CA, Ortega-Loayza AG, Kent G, Cassidy PB, Hu R, Choate K, Wang Z, Liu Y, Greiling TM. Haynes D, et al. Among authors: cassidy pb. JAMA Dermatol. 2020 Jun 1;156(6):668-675. doi: 10.1001/jamadermatol.2020.0932. JAMA Dermatol. 2020. PMID: 32293641 Free PMC article. Clinical Trial.

9

CDKN2A testing and genetic counseling promote reductions in objectively measured sun exposure one year later.

Stump TK, Aspinwall LG, Drummond DM, Taber JM, Kohlmann W, Champine M, Cassidy PB, Petrie T, Liley B, Leachman SA. Stump TK, et al. Among authors: cassidy pb. Genet Med. 2020 Jan;22(1):26-34. doi: 10.1038/s41436-019-0608-9. Epub 2019 Aug 2. Genet Med. 2020. PMID: 31371819 Free PMC article.

10

Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib-resistant BRAF^V600E mutation bearing metastatic melanoma cells.

Carpenter EL, Chagani S, Nelson D, Cassidy PB, Laws M, Ganguli-Indra G, Indra AK. Carpenter EL, et al. Among authors: cassidy pb. Mol Carcinog. 2019 Sep;58(9):1680-1690. doi: 10.1002/mc.23068. Epub 2019 Jun 18. Mol Carcinog. 2019. PMID: 31211467 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year